Omega Healthcare Investors (OHI) Downgraded to “Hold” at ValuEngine
ValuEngine cut shares of Omega Healthcare Investors (NYSE:OHI) from a buy rating to a hold rating in a research report report published on Wednesday.
A number of other analysts also recently commented on OHI. Zacks Investment Research upgraded Omega Healthcare Investors from a sell rating to a hold rating in a research report on Thursday, August 16th. began coverage on Omega Healthcare Investors in a research report on Tuesday, October 2nd. They set a neutral rating and a $31.00 target price on the stock. They noted that the move was a valuation call. Mitsubishi UFJ Financial Group reissued a neutral rating on shares of Omega Healthcare Investors in a report on Tuesday, October 2nd. Stifel Nicolaus set a $34.00 price target on Omega Healthcare Investors and gave the stock a hold rating in a report on Monday, November 5th. Finally, TheStreet raised Omega Healthcare Investors from a c rating to a b- rating in a report on Thursday, November 8th. Eight research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company has an average rating of Hold and an average target price of $32.50.
OHI opened at $36.70 on Wednesday. The company has a current ratio of 4.17, a quick ratio of 4.17 and a debt-to-equity ratio of 1.21. The firm has a market cap of $7.37 billion, a price-to-earnings ratio of 11.84, a PEG ratio of 7.11 and a beta of 0.17. Omega Healthcare Investors has a one year low of $24.90 and a one year high of $38.34.
In other news, insider Michael Ritz sold 6,000 shares of the business’s stock in a transaction on Friday, November 16th. The stock was sold at an average price of $34.75, for a total value of $208,500.00. Following the completion of the transaction, the insider now directly owns 10,076 shares of the company’s stock, valued at $350,141. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Steven J. Insoft sold 25,000 shares of the business’s stock in a transaction on Tuesday, December 11th. The stock was sold at an average price of $37.25, for a total value of $931,250.00. Following the completion of the transaction, the insider now directly owns 315,720 shares of the company’s stock, valued at $11,760,570. The disclosure for this sale can be found here. Over the last three months, insiders sold 36,000 shares of company stock valued at $1,321,750. Insiders own 1.65% of the company’s stock.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Belpointe Asset Management LLC acquired a new position in Omega Healthcare Investors in the third quarter valued at $131,000. Stratos Wealth Partners LTD. acquired a new position in Omega Healthcare Investors in the third quarter valued at $132,000. Meeder Asset Management Inc. increased its stake in Omega Healthcare Investors by 69.3% in the third quarter. Meeder Asset Management Inc. now owns 4,184 shares of the real estate investment trust’s stock valued at $137,000 after purchasing an additional 1,712 shares during the last quarter. Point72 Hong Kong Ltd acquired a new position in Omega Healthcare Investors in the second quarter valued at $147,000. Finally, Bell Rock Capital LLC acquired a new position in Omega Healthcare Investors in the third quarter valued at $158,000. 73.42% of the stock is owned by institutional investors.
Omega Healthcare Investors Company Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
See Also: Should you buy a closed-end mutual fund?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.